The audit

Nov 11, 2026

Checked: tendon recovery. Four compounds graded against six published sources.

Nov 11, 2026

Thrown out: "BPC-157 is proven to heal tendons."

35 animal or lab studies. 1 human study, 12 people.

Nov 11, 2026

Thrown out: eye and skin trials of thymosin beta-4 as proof TB-500 heals tendons.

different molecule, different body part

Nov 11, 2026

Flagged: five sellers with FDA warning letters from August 2026.

Nov 11, 2026

Checked: all 28 compounds in the stack builder. 25 are source-checked. Three supplements are still marked draft.

Nov 11, 2026

Changed: retatrutide grade from A to B. The published trial is mid-stage and the drug is not approved.

Nov 11, 2026

Added: 14 over-the-counter supplements to the stack builder.

Nov 11, 2026

Changed: grade wording. A now means strong human proof. B covers small, early or mixed results.

Nov 11, 2026

Added: a what-to-expect timeline, a daily plan and eight example stacks to the stack builder, plus a supplements page.

Nov 11, 2026

Corrected: Bacopa improves memory.

the review found faster attention, not memory

Nov 11, 2026

Corrected: Magnesium L-threonate improves sleep.

the trial could not tell

Nov 11, 2026

Corrected: the failed ALS trial tested a TUDCA combination drug, not TUDCA alone.

Nov 11, 2026

Checked: every outside link on the site, twice. Two podcast links and one book link now go to the publisher instead of a middleman. Five public look-up sources added.

Nov 11, 2026

Checked: the last three draft supplements. All 28 compounds are now source-checked.

Nov 11, 2026

Corrected: NAC makes the body's main antioxidant.

it supplies a building block, that is all the sources say

Nov 11, 2026

Corrected: NAC upsets the stomach.

same rate on placebo in the bronchitis trials

Nov 12, 2026

Live: the site opened at workedinrats.com with one-tap login, the forum, private feedback and a privacy page.

Nov 12, 2026

Checked: muscle and fat loss. 28 published sources, plus two FDA pages.

Nov 12, 2026

Left out: how to manage a blood sugar crash from insulin.

more than half of non-diabetic users crashed. one passed out. a separate report describes a coma. we will not write that how-to.

Nov 12, 2026

Updated: BPC-157 pharmacy rules. HHS issued a temporary policy in late October not to act against licensed compounding of six peptides.

temporary, and not an approval

Nov 12, 2026

Checked: sleep and stress. 20 published sources.

Nov 12, 2026

Checked: anti-aging. 17 published sources, a trial registry entry and an FDA page.

Nov 12, 2026

Checked: skin and hair. 17 published sources and two FDA pages.

Nov 12, 2026

Checked: SARMs and SERMs. 16 published sources, plus FDA, USADA, WADA and a drug label.

only 23 of 44 products tested contained a SARM

Nov 12, 2026

Added: 13 compounds to the stack builder, including melatonin, creatine, epitalon, MOTS-c and four sold as SARMs. 41 in total.

Nov 12, 2026

Checked: gut health. 19 published sources and a trial registry entry.

Nov 12, 2026

Added: 34 more compounds to the stack builder: gym supplements, testosterone boosters, gut, libido and the newest weight-loss drugs. 75 in total.

Nov 12, 2026

Live: login emails now reach anyone who signs up. They come from login@workedinrats.com and are sent through Resend. The privacy page says so.

Nov 12, 2026

Re-checked: the 45 oldest stack-builder entries, one by one, against published sources. 15 were corrected. All 75 compounds now list their sources when you open them.

Nov 12, 2026

Corrected: Cardarine. We said it had no human results. A 12-week trial in 268 adults measured blood fats.

we got this one wrong

Nov 12, 2026

Corrected: the MK-677 source link pointed at the wrong paper. It now opens the hip-fracture trial.

Nov 12, 2026

Corrected: BPC-157 human studies. We said one. A 2026 review counts three, about 30 people in all, none with a comparison group.

Nov 12, 2026

Changed: retatrutide grade from B back to A. A final-stage trial in 2,339 adults was published on September 29, 2026. It is still not approved.

Nov 12, 2026

Updated: saffron and magnesium L-threonate, for 2026 trials and reviews.

Nov 12, 2026

Removed: the Brain and focus placeholder from the goals page. That page is not being built for now.

Nov 12, 2026

Outside review: a fresh reader went through every page before launch and listed what breaks our own rules. We fixed the wording that read like advice, the flat "no study exists" claims, and the lines that disagreed with each other.

Nov 12, 2026

Changed: the stack builder now starts empty. "Ready-made stacks" became "Stacks people ask about", and "What to expect" became "What studies saw, and when".

Nov 12, 2026

Removed: amounts. Upper limits now point to the NIH fact sheet instead of printing a number.

Nov 12, 2026

Changed: Semax, Selank and phenibut now cite journal papers and the FDA. The old source was a company that sells peptides.

we do not link to peptide sellers

Nov 12, 2026

Changed: vendor watch now links each name to the FDA's own letter. The unfinished lab scorecards section is gone.

Nov 12, 2026

Changed: the fonts and the login code are now served from this site. No Google or other outside network loads with the page.

Nov 12, 2026

Added: forum rules on sourcing and reporting, an adults-only line, and plainer privacy details.

Nov 12, 2026

Added: each goal page now has its own web address, such as workedinrats.com/muscle. Those pages load without JavaScript.

Nov 12, 2026

Added: limits on how fast anyone can post or send feedback, so the forum cannot be flooded.

Nov 12, 2026

Added: one page for each compound, 72 in all, with its grade, what studies saw, the trade-off and its sources.

Nov 12, 2026

Added: the shelf. 39 over-the-counter supplements, each with its grade and a plain Amazon search. No affiliate tag. No peptides, SARMs or prescription drugs.

we earn nothing if you buy

Nov 12, 2026

Added: an Ask page. Send a question with no login. Answers are posted with no name.

Nov 12, 2026

Added: "How it was given in studies" on every compound page: by mouth, under the skin, into a vein, on the skin, or never tested in people. Each line comes from the trial paper, the FDA label or the trial registry.

what the studies did, not a how-to

Nov 12, 2026

Could not confirm: how AOD-9604 and epitalon were given in their human studies. Their pages say so.

Nov 12, 2026

Added: Him, her and other. Who was actually in the studies, where results differed by sex, and the plain science of why. Every line links to its source.

Nov 13, 2026

Added: the count, one page that adds up the grades. A share card and a small badge for every compound. A page for journalists.

the badge grades the compound, not a product

Nov 13, 2026

Added: the weekly. One short email a week on new trials, rule changes and our own corrections. Every issue is also posted on the site.

your email is used only to send it

Open

Watching: whether HHS makes the compounding policy permanent, and results from the JUMPFOOD collagen trial.